Form 8.3 - AGI Therapeutics plc (6018V)

TIDMAGI

RNS Number : 6018V

AGI Therapeutics plc

16 January 2012

 
                                FORM 8.3 
 
                          IRISH TAKEOVER PANEL 
 
             DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER 
           PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) 
 
             DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT 
                   SECURITIES REPRESENTING 1% OR MORE 
 
                           1. KEY INFORMATION 
================================================================ 
Name of person dealing        Paul Johnson 
 (Note 1) 
============================  ================================== 
Company dealt in              AGI Therapeutics plc 
============================  ================================== 
Class of relevant security    Ordinary Shares EUR0.01 
 to which the dealings         each 
 being disclosed relate 
 (Note 2) 
============================  ================================== 
Date of dealing               13.1.12 
============================  ================================== 
 
 
  2. INTERESTS AND SHORT POSITIONS 
 
  (a) Interests and short positions (following 
  dealing) in the class of relevant security dealt 
  in (Note 3) 
================================================================ 
                                         Long              Short 
============================  ===============  ================= 
                              Number (%)        Number (%) 
============================  ===============  ================= 
(1) Relevant securities           524,715 
============================  ===============  ================= 
(2) Derivatives (other 
 than options) 
============================  ===============  ================= 
(3) Options and agreements 
 to purchase/sell 
============================  ===============  ================= 
Total 
============================  ===============  ================= 
 (b) Interests and short positions in relevant 
  securities of the company, other than the class 
  dealt in (Note 3) 
================================================================ 
Class of relevant security:              Long              Short 
============================  ===============  ================= 
                              Number (%)        Number (%) 
============================  ===============  ================= 
 
 (1) Relevant securities 
============================  ===============  ================= 
 
 (2) Derivatives (other 
 than options) 
============================  ===============  ================= 
 
 (3) Options and agreements 
 to purchase/sell 
============================  ===============  ================= 
 
 Total 
============================  ===============  ================= 
 
 
 
 
                                                 1 February 2009 
 
 
   3. DEALINGS (Note 4) 
 
    (a) Purchases and sales 
   ================================================================================================================ 
 
    Purchase/sale                        Number of relevant securities                     Price per unit 
                                                                                           (Note 5) 
   ============================  ===================================================  ============================= 
s  Sale                                                254,067                                  GBP0.0706 
    Sale                                               250,000                                  GBP0.0707 
   ============================  ===================================================  ============================= 
 
 
    (b) Derivatives transactions (other than options 
    transactions) 
   ================================================================================================================ 
   Product 
    name, e.g.          Nature of transaction            Number of relevant                         Price per 
    CFD                                                  securities                                 unit 
                        (Note 6) 
                                                         (Note 7)                                   (Note 5) 
   ==================  ===============================  ========================================  ================= 
 
 
 
    (c) Options transactions in respect of existing 
    relevant securities 
 
    (i) Writing, selling, purchasing or varying 
   ================================================================================================================ 
   Product       Writing,                 Number of          Exercise    Type,              Expiry    Option 
    name, e.g.    selling,                 securities         price       e.g. American,     date     money 
    call option   purchasing,              to which                       European                    paid/received 
                  varying                  the option                     etc.                        per unit 
                  etc.                     relates (Note                                              (Note 
                                           7)                                                         5) 
   ============  =======================  ================  ===========  =================  ========  ============= 
 
 
 
 
    (ii) Exercising 
   ================================================================================================================ 
   Product name,                        Number of securities                              Exercise price 
    e.g. call option                                                                       per unit (Note 
                                                                                           5) 
   ============================  ===================================================  ============================= 
 
 
 
 
    (d) Other dealings (including transactions in 
    respect of new securities) (Note 4) 
   ================================================================================================================ 
   Nature of transaction                Details                                           Price per unit 
    (Note 8)                                                                               (if applicable) 
                                                                                           (Note 5) 
   ============================  ===================================================  ============================= 
 
 
 
 
 
 
 
                                                                                                    1 February 2009 
 
 
 
4. OTHER INFORMATION 
 
 Agreements, arrangements or understandings relating 
 to options or derivatives 
======================================================== 
Full details of any agreement, arrangement or 
 understanding between the person disclosing and 
 any other person relating to the voting rights 
 of any relevant securities under any option referred 
 to on this form or relating to the voting rights 
 or future acquisition or disposal of any relevant 
 securities to which any derivative referred to 
 on this form is referenced. If none, this should 
 be stated. 
======================================================== 
 
 
 
 
 Is a Supplemental Form 8 attached? (Note 9) NO 
======================================================== 
Date of disclosure                 13.1.12 
=================================  ===================== 
Contact name                       Paul Johnson 
=================================  ===================== 
Telephone number                   [phone] 
=================================  ===================== 
If a connected EFM, name 
 of offeree/offeror with 
 which connected 
=================================  ===================== 
If a connected EFM, state 
 nature of connection (Note 
 10) 
=================================  ===================== 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                         1 February 2009 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETUNUKRUUAAARR